18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma
Primary central nervous system (CNS) lymphoma is an aggressive non-Hodgkin lymphoma
with poor prognosis. We evaluated pretreatment 18F-FDG PET as a prognostic marker in …
with poor prognosis. We evaluated pretreatment 18F-FDG PET as a prognostic marker in …
Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma
D Albano, M Bertoli, M Battistotti, C Rodella… - Annals of nuclear …, 2018 - Springer
Objective Primary brain lymphoma is an aggressive extranodal non-Hodgkin lymphoma with
poor prognosis. Many possible prognostic factors are investigated with controversial results …
poor prognosis. Many possible prognostic factors are investigated with controversial results …
The diagnostic role of 18F-FDG PET for primary central nervous system lymphoma
S Yamaguchi, K Hirata, H Kobayashi, T Shiga… - Annals of nuclear …, 2014 - Springer
Abstract Objective 18 F-FDG PET has become one of the most important methods for
studying malignant lymphoma, but its diagnostic role for primary central nervous system …
studying malignant lymphoma, but its diagnostic role for primary central nervous system …
18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: differentiation from glioblastoma and correlation with DWI
W Zhou, J Wen, F Hua, W Xu, X Lu, B Yin… - European Journal of …, 2018 - Elsevier
Abstract Objectives 18 F-fluorodeoxyglucose (FDG) positron emission tomography
(PET)/computed tomography (CT) is useful for the detection of cancerous lesions, and FDG …
(PET)/computed tomography (CT) is useful for the detection of cancerous lesions, and FDG …
18F-FDG PET/CT in primary brain lymphoma
D Albano, G Bosio, M Bertoli, R Giubbini… - Journal of Neuro …, 2018 - Springer
The actual role of 18F-FDG PET/CT in evaluating primary brain lymphoma is still an open
issue. Brain lymphoma usually show elevated 18F-FDG uptake, often higher than other …
issue. Brain lymphoma usually show elevated 18F-FDG uptake, often higher than other …
Prognostic value of pretreatment 18F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment
N Kawai, HN Zhen, K Miyake, Y Yamamaoto… - Journal of neuro …, 2010 - Springer
The purpose of this retrospective study was to evaluate the prognostic value of 18 F-
fluorodeoxyglucose (FDG) positron emission tomography (PET) in immunocompetent …
fluorodeoxyglucose (FDG) positron emission tomography (PET) in immunocompetent …
Prognostic significance of interim 11C-methionine PET/CT in primary central nervous system lymphoma
Purpose Primary central nervous system lymphoma (PCNSL) has a poor prognosis. There
has been limited study evaluating the role of interim PET/CT in PCNSL. This prospective …
has been limited study evaluating the role of interim PET/CT in PCNSL. This prospective …
[HTML][HTML] 18F-FDG PET in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma
N Kawai, K Miyake, Y Yamamoto… - BioMed Research …, 2013 - hindawi.com
This paper summarizes the usefulness and limitation of positron emission tomography (PET)
with 18 F-fluorodeoxyglucose (18 F-FDG) in the diagnosis and treatment of primary central …
with 18 F-fluorodeoxyglucose (18 F-FDG) in the diagnosis and treatment of primary central …
Common malignant brain tumors: can: 18: F-FDG PET/CT aid in differentiation?
NC Purandare, A Puranik, S Shah… - Nuclear medicine …, 2017 - journals.lww.com
Objectives The objectives of this study were to evalute the metabolic characteristics of
common malignant space-occupying lesions (SOL) of the brain and to determine the utility of …
common malignant space-occupying lesions (SOL) of the brain and to determine the utility of …
Utility of brain FDG-PET in primary CNS lymphoma.
NA Mohile, LM Deangelis, LE Abrey - Clinical Advances in …, 2008 - europepmc.org
18Fluoro-deoxyglucose positron emission tomography (FDG-PET) imaging has been widely
incorporated into the management of systemic non-Hodgkin lymphoma. However, its utility …
incorporated into the management of systemic non-Hodgkin lymphoma. However, its utility …